Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment
Relative importance estimates suggest that, on average, respondents with episodic migraine preferred an oral pill over monthly or quarterly injections and infusions. Respondents also preferred to avoid treatment-related nausea and constipation. The predicted choice probability results further suggest a preference for a daily oral pill, given that seven of 10 respondents, on average, would prefer a profile similar to atogepant over profiles similar to monoclonal antibodies administered intravenously or by self-injection.
Authors
- Richard B. Lipton (ORCID: https://orcid.org/0000-0003-2652-2897)
- Pranav Gandhi (ORCID: https://orcid.org/0009-0008-8317-7712)
- Cooper Bussberg (ORCID: https://orcid.org/0000-0002-7854-3596)
- Stephanie J. Nahas (ORCID: https://orcid.org/0000-0001-8846-8393)
- Kelley Myers (ORCID: https://orcid.org/0000-0002-0936-5677)
- Jonathan Stokes
Institutions
- Albert Einstein College of Medicine (US)
- Thomas Jefferson University (US)
- AbbVie (United States) (US)
- RTI Health Solutions (US)
Publication Details
- Journal
- Headache The Journal of Head and Face Pain
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1111/head.14974
- Citations
- 3
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.41